Literature DB >> 10428911

Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model.

A Lozniewski1, A Duprez, C Renault, F Muhale, M C Conroy, M Weber, A Le Faou, F Jehl.   

Abstract

The delivery of antibiotics into Helicobacter pylori-infected human stomachs is still poorly understood. Human embryonic gastric xenografts in nude mice have recently been proposed as a new model for the study of H. pylori infection. Using this model, we compared the penetration of amoxicillin, after intraperitoneal administration of a dose of 20 mg/kg of body weight, into the gastric mucosae of infected and uninfected xenografts. The concentrations of this drug in serum and superficial gastric mucosae were determined at 20 min and 1 and 3 h after injection. Ten mice with H. pylori-infected grafts (n = 5) or uninfected grafts (n = 5) were studied. Mucosal samples were obtained by cryomicrotomy. The concentrations in serum were similar to those obtained in the serum of humans after oral administration of 1 g of amoxicillin. The mean area under the tissue concentration-versus-time curve from 0 to 3 h obtained for mice with infected grafts was significantly higher than that obtained for the animals with uninfected grafts (P = 0.01). These results suggest that the penetration of amoxicillin into the superficial gastric mucosa may be substantially increased in the case of H. pylori infection. Thus, human xenografts in nude mice represent a new, well-standardized model for investigation of systemic delivery of drugs into H. pylori-infected gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428911      PMCID: PMC89389     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Authors:  C A McNulty; J C Gearty; B Crump; M Davis; I A Donovan; V Melikian; D M Lister; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach.

Authors:  J W Stone; R Wise; I A Donovan; J Gearty
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

3.  Treatment failure of ofloxacin in Campylobacter pylori infection.

Authors:  Y Glupczynski; M Labbe; A Burette; M Delmee; V Avesani; C Bruck
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

4.  Human embryonic gastric xenografts in nude mice: a new model of Helicobacter pylori infection.

Authors:  A Lozniewski; F Muhale; R Hatier; A Marais; M C Conroy; D Edert; A le Faou; M Weber; A Duprez
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 5.  The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.

Authors:  E Bayerdörffer; R Ottenjann
Journal:  Scand J Gastroenterol Suppl       Date:  1988

6.  -amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man.

Authors:  E A Croydon; R Sutherland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

7.  Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease.

Authors:  G Bode; P Malfertheiner; H Ditschuneit
Journal:  Scand J Gastroenterol Suppl       Date:  1988

8.  Pharmacokinetic, bacteriological and clinical aspects on the use of doxycycline in patients with active duodenal ulcer associated with Campylobacter pylori.

Authors:  P Unge; H Gnarpe
Journal:  Scand J Infect Dis Suppl       Date:  1988

9.  Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa.

Authors:  C A McNulty; J C Dent; G A Ford; S P Wilkinson
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

10.  Evidence for weakening of gastric mucus integrity by Campylobacter pylori.

Authors:  J Sarosiek; A Slomiany; B L Slomiany
Journal:  Scand J Gastroenterol       Date:  1988-06       Impact factor: 2.423

View more
  4 in total

1.  Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.

Authors:  Hai-lun Zheng; Yong-mei Hu; Jun-jun Bao; Jian-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

2.  Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.

Authors:  P V Sherwood; J I D Wibawa; J C Atherton; N Jordan; D Jenkins; D A Barrett; P N Shaw; R C Spiller
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 3.  Helicobacter pylori diagnosis and therapy in the era of antimicrobial stewardship.

Authors:  Akiko Shiotani; Priya Roy; Hong Lu; David Y Graham
Journal:  Therap Adv Gastroenterol       Date:  2021-12-21       Impact factor: 4.409

4.  Evaluation of the benefit of addition of clidinium C to a Helicobacter pylori eradication regimen.

Authors:  Maryam Chorami; Homayoun Zojaji; Nosratollah Naderi; Bijan Moghimi-Dehkordi; Dariush Mirsattari; Hamid Mohaghegh Shalmani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.